Article
Common SPINK-1 mutations do not predispose to the development of non-alcoholic fatty liver disease.
Annals of hepatology - 1 Jan 2000
Oruc Nevin, Ozutemiz Omer, Berdeli Afig, Ersoz Galip, Gunsar Fulya, Karasu Zeki, Ilter Tankut, Batur Yucel, Akarca Ulus Salih
Abstract excerpt
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is common in obese and diabetics. Serine protease inhibitor Kazal-1 (SPINK-1) protein is highly expressed in the liver and adipose tissue of diabetic and obese suggesting its role in NAFLD. SPINK-1 also behaves as an acute phase reactant protein. Some genetic factors including the genetic variations in SPINK-1 protein have been linked to chronic pancreatitis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
